Medibiofarma participated in the “Startup Spotlight” event sponsored by Eli Lilly in the 13th edition of the annual BIO-Europe Spring conference 2019 held in Vienna. Julio Castro, CSO of...

Medibiofarma announces the completion of a new financing round of 2 million euros, with the financial support of its founder team and the incorporation of new partners, among them, Sodena, a...

Compound MBF-251, a novel EP2/EP4 dual antagonist for the treatment of cancer.  The compound will start IND enabling studies the second quarter 2019.